Trial Profile
TBE (Tick-borne Encephalitis ) Vaccination in Allergic Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Tick-borne encephalitis vaccine (Primary)
- Indications Encephalitis virus infections
- Focus Pharmacodynamics
- 26 Mar 2018 Status changed from recruiting to completed.
- 05 Aug 2015 New trial record